Method for measuring in vivo inhibition of intracellular RNase

    公开(公告)号:US10663456B2

    公开(公告)日:2020-05-26

    申请号:US15746570

    申请日:2016-07-06

    Abstract: The present invention provides means for evaluating harmfulness of a chemical substance before occurrence of cell death, that is, more quickly and sensitively compared to conventional methods wherein the remaining viable cell count is determined using a reductive coloring reagent after a period of time required for occurrence of cell death due to the chemical substance. A double-stranded RNA probe comprising an RNA strand labeled with a fluorescent dye A that emits fluorescence, and an RNA strand labeled with a fluorescent dye B that quenches emission from a fluorescent dye in the vicinity thereof, wherein the fluorescence is quenched in a double-stranded state due to occurrence of fluorescence resonance energy transfer (FRET) between the two kinds of fluorescent dyes. When the probe is introduced into a cell and the cell is in a normal state, the double-stranded RNA is quickly degraded by activity of intracellular ribonuclease to cause cancellation of the FRET state, allowing fluorescence emission of the fluorescent dye A. On the other hand, in cases where the cell is harmfully influenced, activity of intracellular ribonuclease is suppressed, so that the double-stranded RNA remains undegraded, and the fluorescent dye A remains quenched due to the influence of the fluorescent dye B. By detecting a decrease in the degradation rate of intracellular RNA based on this principle, harmfulness of a chemical substance can be quickly and sensitively evaluated before occurrence of cell death.

    Sample analysis system, learned model generation method, and sample analysis method

    公开(公告)号:US12117343B2

    公开(公告)日:2024-10-15

    申请号:US17904383

    申请日:2020-12-10

    CPC classification number: G01J3/443 G01N21/255 G01N21/31 G01J2003/2859

    Abstract: Provided is a sample analysis system including: a droplet device configured to intermittently introduce a sample to a measurement region set in plasma; a light emission detection device configured to detect light emission in the measurement region at a detection timing, the detection timing being set at a predetermined cycle in advance; and an analysis device configured to analyze the sample based on the detected light emission, wherein the analysis device is provided with: a distribution computing unit configured to compute a time-spatial light intensity distribution based on the detected light emission, the time-spatial light intensity distribution being a distribution of a light intensity according to the detection timing, a position in the measurement region, and a wavelength component of the light emission; and a characteristic specifying unit configured to compute, from the time-spatial light intensity distribution, a feature amount that correlates with a sample characteristic indicating a property of the sample and specify the sample characteristic based on the feature amount.

    Artificial bioluminescent enzyme
    4.
    发明授权

    公开(公告)号:US10533231B2

    公开(公告)日:2020-01-14

    申请号:US14438534

    申请日:2013-09-18

    Abstract: The invention relates to establishment of a series of artificial luciferases based on artificial amino acid sequences extracted by amino acid alignment of copepod-derived luciferase sequences in a database based on amino acid similarity. The invention provides high luminescence intensity, high luminescence stability, and a spectrum with increased wavelength as luminescence characteristics. A series of artificial luciferases (ALuc) was established. The group of ALucs has superior luminescence characteristics, such as an increase in luminescence intensity, an increase in luminescence stability, or an increase in wavelength of the luminescence spectrum, which were not obtained before. Further, by using the artificial luciferases (ALuc) of the invention, it is possible to provide a novel, superior bioassay system, such as a bioluminescent probe, two-hybrid assay, a luminescent capsule, or the like having improved measurement function.

    ARTIFICIAL BIOLUMINESCENT ENZYME
    6.
    发明申请
    ARTIFICIAL BIOLUMINESCENT ENZYME 审中-公开
    人工生物发光酶

    公开(公告)号:US20150284813A1

    公开(公告)日:2015-10-08

    申请号:US14438534

    申请日:2013-09-18

    Abstract: The invention relates to establishment of a series of artificial luciferases based on artificial amino acid sequences extracted by amino acid alignment of copepod-derived luciferase sequences in a database based on amino acid similarity. The invention provides high luminescence intensity, high luminescence stability, and a spectrum with increased wavelength as luminescence characteristics. A series of artificial luciferases (ALuc) was established. The group of ALucs has superior luminescence characteristics, such as an increase in luminescence intensity, an increase in luminescence stability, or an increase in wavelength of the luminescence spectrum, which were not obtained before. Further, by using the artificial luciferases (ALuc) of the invention, it is possible to provide a novel, superior bioassay system, such as a bioluminescent probe, two-hybrid assay, a luminescent capsule, or the like having improved measurement function.

    Abstract translation: 本发明涉及基于氨基酸相似性在数据库中建立基于人猿氨基酸序列的人工荧光素酶序列,所述人工氨基酸序列是通过桡足类衍生的萤光素酶序列的氨基酸比对提取的。 本发明提供高发光强度,高发光稳定性和具有增加的波长作为发光特性的光谱。 建立了一系列人造荧光素酶(ALuc)。 该组ALuc具有优异的发光特性,例如发光强度的增加,发光稳定性的增加或发光光谱的波长增加,这在以前未获得。 此外,通过使用本发明的人造荧光素酶(ALuc),可以提供具有改善的测量功能的新型优异的生物测定系统,例如生物发光探针,双杂交测定,发光胶囊等。

Patent Agency Ranking